Agno Pharma

Established in 2004, Agno Pharma is a leading global CDMO headquartered in Bethlehem, PA, USA. Specializing in comprehensive cGMP manufacturing solutions, we excel in developing and producing regulatory starting materials (RSMs), intermediates, and active pharmaceutical ingredients (APIs), with specializations in highly-potent and sterile APIs, and flow-based chemistry. We also excel in complex sterile drug product formulations, such as injectable suspensions, emulsions, long-acting implants, and other implantable products. To learn more, please visit http://www.agnopharma.com/